Latest Financial Results
Q1 2023
Quarter Ended Mar 31, 2023
Latest 10-K
View Latest 10-KStock Information
Symbol
NYSE American: NAVBPrice
Change
Volume
52 week Low/High
Day Low/High
Company Overview
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. The company, founded in 1983, maintains headquarters in Dublin, Ohio.
Investor Contact Information
Navidea Biopharmaceuticals, Inc.
4995 Bradenton Avenue
Suite 240
Dublin, OH 43017
Investor Relations
Joseph Meyer
Director, Finance and Accounting
T: (614) 822-2370
jmeyer@navidea.com
Transfer Agent
Continental Stock Transfer & Trust Company
1 State Street
30th Floor
New York, NY 10004-1561
USA
T: 212-509-4000
cstmail@continentalstock.com
http://www.continentalstock.com